Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Valneva Switches Focus to Bilateral Discussions to Supply its Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001

americanpharmaceuticalreviewApril 22, 2021

Tag: VLA2001 , Valneva , COVID-19

PharmaSources Customer Service